Keywords: fda, grants, abilify, priority, review, status, japanese

FDA grants Abilify priority review status

Article | 26 November 2007

Print This

Japanese drug firm Otsuka Pharmaceutical and USA-based drug major Bristol-Myers Squibb say that the Food and Drug Administration has accepted ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in